Hirohisa Tsujinoue Selected Research

Hirohisa Tsujinoue Research Topics

Disease

7	Neoplasms (Cancer) 07/2004 - 04/2002
5	Hepatocellular Carcinoma (Hepatoma) 07/2004 - 04/2002
4	Liver Cirrhosis (Hepatic Cirrhosis) 02/2005 - 07/2002
4	Fibrosis (Cirrhosis) 02/2005 - 07/2002
4	Carcinogenesis 06/2004 - 07/2002
1	Colitis 11/2006
1	Neoplasm Metastasis (Metastasis) 06/2004

Drug/Important Bio-Agent (IBA)

5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2004 - 04/2002
4	Perindopril FDA LinkGeneric 02/2005 - 06/2002
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2005 - 06/2002
4	Messenger RNA (mRNA)IBA 06/2003 - 04/2002
3	Tissue Inhibitor of Metalloproteinase-1IBA 09/2003 - 10/2002
2	Interferon-betaIBA 02/2005 - 12/2003
2	Hydroxyproline (4 Hydroxyproline)IBA 02/2005 - 07/2002
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 06/2004 - 12/2003
2	CDAA (Randox)IBA 07/2003 - 07/2002
2	Amino Acids FDA Link 07/2003 - 07/2002
2	Choline (Choline Chloride)IBA 07/2003 - 07/2002
2	EnzymesIBA 07/2003 - 07/2002
2	Matrix Metalloproteinases (MMPs)IBA 06/2003 - 10/2002
1	Neuraminidase (Sialidase)IBA 11/2006
1	Oseltamivir (Tamiflu)FDA Link 11/2006
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 07/2004
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2004
1	Trientine (Trien)FDA Link 09/2003
1	Chelating AgentsIBA 09/2003
1	CopperIBA 09/2003
1	Protein Kinase CIBA 09/2003
1	Angiotensin IIIBA 09/2003
1	saiko-keishi-to (TJ10)IBA 07/2003
1	Plant ExtractsIBA 07/2003
1	Biomarkers (Surrogate Marker)IBA 07/2003
1	shosaiko-to (TJ9)IBA 07/2003
1	Glutathione Transferase (Glutathione S-Transferase)IBA 07/2003
1	Caspase 3 (Caspase-3)IBA 10/2002
1	ProcollagenIBA 10/2002
1	CollagenIBA 07/2002
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 07/2002
1	Tetracycline (Achromycin)FDA LinkGeneric 06/2002
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2002
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2002
1	Monoclonal AntibodiesIBA 04/2002

Therapy/Procedure

1	Therapeutics 02/2005
1	Transplantation 07/2004